Advances in Biomarkers for Immunotherapy of Non-small Cell Lung Cancer
Lung cancer is a malignant tumor with the highest mortality in the world. The most common pathological type of lung cancer is non-small cell lung cancer (NSCLC). In recent years, immunotherapy has brought about epoch-making changes in the treatment of NSCLC. In particular, immune checkpoint inhibito...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | ZH |
| Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/ae484970d4ee4d4ab5327fcf84f9f91a |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|